JPH203 (Nanvuranlat) Mechanism of Action: LAT1 Inhibition in Biliary Tract Cancer Cell Research

JPH203 (Nanvuranlat) MOA:Targeting LAT1/Amino Acid Metabolism Pathway for Biliary Tract Cancer Clinical Research

🎯 check JPH203 (Nanvuranlat) product page

JPH203 (Nanvuranlat) is a selective, competitive LAT1 inhibitor. It affects mTORC1 and ATF4/CHOP signaling pathways by blocking LAT1-mediated essential amino acid uptake, effectively inhibiting cancer cell proliferation, viability, and migration.

Primary Applications and Mechanism of Action